Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-065100·Autolus Therapeutics plc
Schedule 13G ownership disclosure
AUTOLUS THERAPEUTICS LTD
Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share. · CUSIP: 05280R100
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Syncona Portfolio Limited
Shares: 28,821,053 · Class: 10.8%
- Syncona Holdings Limited
Shares: 28,821,053 · Class: 10.8%
- Syncona Investment Management Limited
Shares: 28,821,053 · Class: 10.8%
- Syncona Limited
Shares: 28,821,053 · Class: 10.8%
- Roel Bulthuis
Shares: 28,821,053 · Class: 10.8%
- Christopher Hollowood
Shares: 28,821,053 · Class: 10.8%
- Kenneth Galbraith
Shares: 28,821,053 · Class: 10.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-065100
- Form type
- SCHEDULE 13G/A
- Filer
- Autolus Therapeutics plc
- CIK
- CIK 1730463
- Filed
- May 07, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership